Tracking the Relative In Vivo Pharmacokinetics of Nanoparticles with PARACEST MRI-Reference-Cited by-同舟云学术

Tracking the Relative In Vivo Pharmacokinetics of Nanoparticles with PARACEST MRI

Published:2009-04-17 Issue:5 Volume:6 Page:1409-1416
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ali M. Meser¹,Yoo Byunghee¹,Pagel Mark D.¹

Affiliation:

1. Department of Radiology, Henry Ford Health System, Detroit, Michigan, and Biomedical Engineering Interdisciplinary Program, and Department of Chemistry,University of Arizona, Tucson, Arizona

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp900040u

Reference27 articles.

1. Nanotechnological applications in medicine

2. Nanoparticle and targeted systems for cancer therapy

3. Role of Nanobiotechnology in Developing Personalized Medicine for Cancer

4. Comparative Chemical Structure and Pharmacokinetics of MRI Contrast Agents

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transition metal Parashift and ParaCEST MRI agents: Current progress and challenges;Coordination Chemistry Reviews;2024-10

2. Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma;Cancers;2024-08-27

3. Co(II) Macrocyclic Complexes with Amide‐Glycinate Pendants as ParaCEST and Liposomal CEST Agents;Chemistry – A European Journal;2024-07-31

4. Energy recruitment via lanthanide-chelate to boost the persistent luminescence of nanophosphor for contrast-enhanced tumor navigation;Chemical Engineering Journal;2023-07

5. Co(ii) complexes of tetraazamacrocycles appended with amide or hydroxypropyl groups as paraCEST agents;Dalton Transactions;2023